105 related articles for article (PubMed ID: 38941393)
1. Mendelian randomization as a cornerstone of causal inference for gut microbiota and related diseases from the perspective of bibliometrics.
Wang J; Li J; Ji Y
Medicine (Baltimore); 2024 Jun; 103(26):e38654. PubMed ID: 38941393
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-6 signaling pathway in Mendelian randomization: A 10-year bibliometric analysis.
Jing S; Wang J; Yang S; Wu H
Medicine (Baltimore); 2024 Apr; 103(14):e37507. PubMed ID: 38579070
[TBL] [Abstract][Full Text] [Related]
3. Bibliometric and visual analysis of intestinal flora and immunity.
Nie K; Deng T; Wang J; Qi L; Liu N; Chen Z; Xia L
Medicine (Baltimore); 2024 Jan; 103(4):e36575. PubMed ID: 38277560
[TBL] [Abstract][Full Text] [Related]
4. Using Mendelian randomization as the cornerstone for causal inference in epidemiology.
Xu J; Li M; Gao Y; Liu M; Shi S; Shi J; Yang K; Zhou Z; Tian J
Environ Sci Pollut Res Int; 2022 Jan; 29(4):5827-5839. PubMed ID: 34431050
[TBL] [Abstract][Full Text] [Related]
5. Research trends on the relationship between gut microbiota and colorectal cancer: A bibliometric analysis.
Wu W; Ouyang Y; Zheng P; Xu X; He C; Xie C; Hong J; Lu N; Zhu Y; Li N
Front Cell Infect Microbiol; 2022; 12():1027448. PubMed ID: 36699721
[TBL] [Abstract][Full Text] [Related]
6. Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review.
Shu Y; Li W; Hu Q; Xiong D
Medicine (Baltimore); 2023 Dec; 102(50):e36478. PubMed ID: 38115325
[TBL] [Abstract][Full Text] [Related]
7. Bibliometric analysis of intestinal microbiota in diabetic nephropathy.
Gao LW; Yang XY; Yu YF; Yin S; Tong KK; Hu G; Jian WX; Tian Z
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8812-8828. PubMed ID: 37782191
[TBL] [Abstract][Full Text] [Related]
8. Bibliometric analysis of the 100 most-cited papers about the role of gut microbiota in irritable bowel syndrome from 2000 to 2021.
Wan C; Kong X; Liao Y; Chen Q; Chen M; Ding Q; Liu X; Zhong W; Xu C; Liu W; Wang B
Clin Exp Med; 2023 Oct; 23(6):2759-2772. PubMed ID: 36522553
[TBL] [Abstract][Full Text] [Related]
9. The interaction between microbiota and immune in intestinal inflammatory diseases: Global research status and trends.
Liu C; Su W; Tan Z; Zhang J; Dong W
Front Cell Infect Microbiol; 2023; 13():1128249. PubMed ID: 36824689
[TBL] [Abstract][Full Text] [Related]
10. Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function-A Two-Sample Mendelian Randomization Study.
Li N; Wang Y; Wei P; Min Y; Yu M; Zhou G; Yuan G; Sun J; Dai H; Zhou E; He W; Sheng M; Gao K; Zheng M; Sun W; Zhou D; Zhang L
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678231
[TBL] [Abstract][Full Text] [Related]
11. Global research progress of gut microbiota and epigenetics: bibliometrics and visualized analysis.
Tian S; Chen M
Front Immunol; 2024; 15():1412640. PubMed ID: 38803501
[TBL] [Abstract][Full Text] [Related]
12. Advances in gut microbiome in metabonomics perspective: based on bibliometrics methods and visualization analysis.
Wang J; Dong P; Zheng S; Mai Y; Ding J; Pan P; Tang L; Wan Y; Liang H
Front Cell Infect Microbiol; 2023; 13():1196967. PubMed ID: 37325519
[TBL] [Abstract][Full Text] [Related]
13. Global research trends in regulating gut microbiome to improve type 2 diabetes mellitus: bibliometrics and visual analysis.
Jiang R; Cong Z; Zheng L; Zhang L; Guan Q; Wang S; Fang J; Chen J; Liu M
Front Endocrinol (Lausanne); 2024; 15():1401070. PubMed ID: 38887274
[TBL] [Abstract][Full Text] [Related]
14. Global publication trends and research hotspots of the gut-liver axis in NAFLD: A bibliometric analysis.
Yang S; Yu D; Liu J; Qiao Y; Gu S; Yang R; Chai X; Wang W
Front Endocrinol (Lausanne); 2023; 14():1121540. PubMed ID: 36967792
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Specific Gut Microbiota and Metabolites on IgA Nephropathy-Based on Mendelian Randomization and Clinical Validation.
Wang F; Li N; Ni S; Min Y; Wei K; Sun H; Fu Y; Liu Y; Lv D
Nutrients; 2023 May; 15(10):. PubMed ID: 37242290
[TBL] [Abstract][Full Text] [Related]
16. Application of Mendelian randomization in the discovery of risk factors for coronary heart disease from 2009 to 2023: A bibliometric review.
Zhong D; Cheng H
Clin Cardiol; 2024 Jan; 47(1):e24154. PubMed ID: 37724687
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota and eye diseases: a bibliometric study and visualization analysis.
Fu X; Tan H; Huang L; Chen W; Ren X; Chen D
Front Cell Infect Microbiol; 2023; 13():1225859. PubMed ID: 37621873
[TBL] [Abstract][Full Text] [Related]
18. The causal relationship between gut microbiota and neuroblastoma: a bidirectional Mendelian randomization analysis and meta-analysis.
Zhang Z; Li D; Xie F; Zhang H
Microbiol Spectr; 2024 Apr; 12(4):e0365623. PubMed ID: 38411074
[TBL] [Abstract][Full Text] [Related]
19. Causal relationship between the gut microbiota and insomnia: a two-sample Mendelian randomization study.
Wang Q; Gao T; Zhang W; Liu D; Li X; Chen F; Mei J
Front Cell Infect Microbiol; 2024; 14():1279218. PubMed ID: 38500501
[TBL] [Abstract][Full Text] [Related]
20. Investigating the causal impact of gut microbiota on glioblastoma: a bidirectional Mendelian randomization study.
Zeng C; Zhang C; He C; Song H
BMC Genomics; 2023 Dec; 24(1):784. PubMed ID: 38110895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
